Anzeige
Mehr »
Login
Samstag, 27.04.2024 Börsentäglich über 12.000 News von 686 internationalen Medien
Geheimtipp: Rasanter Aufstieg, Branchenrevolution und Jahresumsatz von 50 Mio. $
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
346 Leser
Artikel bewerten:
(1)

Tej Kohli & Ruit Foundation: Tej Kohli and Dr Sanduk Ruit screen 115,578 patients in one year after launching a joint mission to break the cycle of poverty blindness in the developing world

LONDON, March 24, 2022 /PRNewswire/ -- Tej Kohli (left) and Dr Sanduk Ruit (right) among the 333 patients who were cured of cataract blindness and severe visual impairment at a three-day surgical outreach camp in Doramba, Nepal, in March 2022.

Tej Kohli (left) and Dr Sanduk Ruit (right) among the 333 patients who were cured of cataract blindness and severe visual impairment at a three-day surgical outreach camp in Doramba, Nepal, in March 2022.

Since launching in March 2021 the London-headquartered Tej Kohli & Ruit Foundation has screened 115,578 patients and cured 11,462 of cataract blindness at 45 outreach camps located in poor and underserved communities within low-income countries.

Last week the charity marked its one-year milestone by staging a three-day microsurgical outreach camp in the remote hills of Nepal after screening 3,251 patients in sixteen localities. 333 of the patients who were identified as blind or severely visually impaired then received a free surgical intervention to cure them of cataracts after being transported by the foundation to its temporary operating theatre at a school in the Dorambah region.

The Tej Kohli & Ruit Foundation is an alliance between philanthropist Tej Kohli and pre-eminent ophthalmologist and eye surgeon Dr Sanduk Ruit. Together in 2022 they plan to undertake a minimum of 60,000 interventions to cure blindness in poor and underserved communities in Asia and Africa as part of a multi-year mission to cure more than 500,000.

A study published by The Lancet has shown that the socioeconomic effect of cataract surgery is substantial, because it allows people to increase their economic productivity by up to 1,500% of the cost of surgery during the first postoperative year.

Tej Kohli, co-founder of the Tej Kohli & Ruit Foundation, said:

"Making large-scale interventions to cure blindness is a means to an end, and that end is extreme poverty reduction. 90% of the world's blind live in low-income countries where untreated blindness and extreme poverty perpetuate each other in an ever-declining cycle. Interventions like ours can act as a circuit breaker and turbo-charge economic development."

Dr Sanduk Ruit, co-founder of the Tej Kohli & Ruit Foundation, said:

"My hope is that we can show the world how large-scale high-volume treatment interventions to cure blindness at the grassroots level can have a major impact in helping to achieve the UN Sustainable Development Goals, including the SGD1 goal to 'end poverty everywhere'."

The Tej Kohli & Ruit Foundation is a restricted fund operating under the auspices of Prism The Gift Fund, registered UK charity number 1099682.

Contact: info@tejkohliruit.com

Website: www.tejkohliruit.com

Instagram: https://www.instagram.com/tejkohliruit/

LinkedIn: https://www.linkedin.com/company/tej-kohli-ruit-foundation/

YouTube: https://www.youtube.com/tejkohliruitfoundation

Medium: https://tejkohliruitfoundation.medium.com/

Photo - https://mma.prnewswire.com/media/1772677/Tej_Kohli_Ruit_Foundation_1.jpg

Großer Insider-Report 2024 von Dr. Dennis Riedl
Wenn Insider handeln, sollten Sie aufmerksam werden. In diesem kostenlosen Report erfahren Sie, welche Aktien Sie im Moment im Blick behalten und von welchen Sie lieber die Finger lassen sollten.
Hier klicken
© 2022 PR Newswire
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.